Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients

  1. Farina, B.
  2. Guerra, A.D.R.
  3. Bermejo-Peláez, D.
  4. Miras, C.P.
  5. Peral, A.A.
  6. Madueño, G.G.
  7. Jaime, J.C.
  8. Vilalta-Lacarra, A.
  9. Pérez, J.R.
  10. Muñoz-Barrutia, A.
  11. Peces-Barba, G.R.
  12. Maceiras, L.S.
  13. Gil-Bazo, I.
  14. Gómez, M.D.
  15. Ledesma-Carbayo, M.J.
Journal:
Journal of Translational Medicine

ISSN: 1479-5876

Year of publication: 2023

Volume: 21

Issue: 1

Type: Article

DOI: 10.1186/S12967-023-04004-X GOOGLE SCHOLAR lock_openOpen access editor HANDLE: https://hdl.handle.net/10171/66057 HANDLE: https://hdl.handle.net/10016/44997
Dadun. Depósito Académico Digital de la Universidad de Navarra: lock_openOpen access Handle
Data source: Scopus